 |
Products |  |
Diseases | | Products |
|
Trials |  |
News |  |
- || KSH01 / TCRx Therap
Enrollment open: KSH01-R02-101 Solid Tumors (clinicaltrials.gov) - Apr 3, 2023
P1, N=50, Recruiting, Sponsor: TCRx Therapeutics Co.Ltd
Not yet recruiting --> Recruiting
- || TCRx_T / TCRx Therap, Zhejiang University
Trial completion date, Trial initiation date, Trial primary completion date, Metastases: TCRx_T Cells for Advanced or Recurrent Gastric/Gastroesophageal Junction Cancer After Failure of First Chemotherapy (clinicaltrials.gov) - Feb 16, 2023
P1, N=50, Not yet recruiting, Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Not yet recruiting --> Recruiting Trial completion date: Aug 2027 --> Mar 2028 | Initiation date: Aug 2022 --> Mar 2023 | Trial primary completion date: Aug 2025 --> Mar 2026
- || KSH01 / TCRx Therap
New P1 trial: KSH01-R02-101 Solid Tumors (clinicaltrials.gov) - Oct 14, 2022
P1, N=50, Not yet recruiting, Sponsor: TCRx Therapeutics Co.Ltd
- || KSH01 / TCRx Therap
New P1 trial: KSH01-TCRT Solid Tumors (clinicaltrials.gov) - Sep 14, 2022
P1, N=50, Recruiting, Sponsor: TCRx Therapeutics Co.Ltd
- | TCRx_T / TCRx Therap, Zhejiang University
New P1 trial, Metastases: TCRx_T Cells for Advanced or Recurrent Gastric/Gastroesophageal Junction Cancer After Failure of First Chemotherapy (clinicaltrials.gov) - Jul 7, 2022
P1, N=50, Not yet recruiting, Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University